Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Radiation Oncology

Figure 3

From: Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis

Figure 3

No significant difference was detected between BAC and non-BAC NSCLC for three-year (A) Local Control (100% vs 86%, p = 0.13) (B) Regional Control (88% vs 80%, p = 0.45). There is a trend toward lower three-year rates of distant control (26% vs 38%, p = 0.053) in patients with BAC vs non-BAC NSCLC (C).

Back to article page